• This Project has received funding from the European Union´s Horizon 2020 research and innovation programme under grant agreement No 945118
RESILIENCE helps you survive cancer with a strong heart
Icon-twitter-x Youtube Facebook Linkedin Instagram

Hospital 12 de Octubre joins RESILIENCE

  • Download PDF
  • Link

On Thursday June 1st Hospital Universitario 12 de Octubre  in Madrid has joined the RESILIENCE project and it will most probably begin to recruit patients in the coming weeks.

Hospital 12 de Octubre obtained in 2020 the Best in Class (BIC) Award for the Best Service in Hematology and Hemotherapy, the BIC for the Best Service in Hematology and Hemotherapy in Chronic Lymphocytic Leukemia and the BIC for the Best Hematology and Hemotherapy Service in Multiple Myeloma.

The Hospital team shares with us a strong involvement in this trial, whose objective is to strengthen the heart of people who have been treated with anthracyclines to overcome cancer.

At the Hospital we have met with Ana Bella García and Alba Gutiérrez de la Peña, hematology clinical trial coordinators, and Ana Jiménez, Principal Investigator of the study and hematologist.

Our RESILIENCE project keeps on growing with the increase in the number of patients and hospitals where it is developed, thanks to the teams that are involved and work hard every day with dedication and strong motivation.

Back to News

Resilience

Cardiac Magnetic Resonance

  • Cardiac magnetic resonance (CMR) it is a technique without radiation, which is considered the gold-standard for the evaluation of cardiac anatomy, function and even tissue composition.

Clinical Trial Synopsis

  • Multinational, prospective, proof of concept phase II, double-blinded, sham-controlled, randomized clinical trial (RCT) to evaluate the efficacy and safety of Remote Ischaemic PreConditioning.

For patients

Legals

Follow Us

Twitter Youtube Facebook Linkedin Instagram
  • This Project has received funding from the European Union´s Horizon 2020 research and innovation programme under grant agreement No 945118

RESILIENCE is a CNIC project with a multidisciplinary consortium | All Rights Reserved 2022

Logotipo Resilience

Are you a patient participating in RESILIENCE? Here you will find useful information about the details of your participation, activities specifically designed for you. You will also be able to contact RESILIENCE researchers.

In accordance with the provisions of Regulation (EU) 2016/679 on the protection of personal data of natural persons (GDPR), the personal information you have provided will be incorporated into the data processing systems of the Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.) for the purpose of attending your registration application in the restricted area for patients participating in the RESILIENCE study. The legal basis for processing your personal data for this purpose is your explicit consent. Your personal data will not be disclosed to any recipients other than those to whom you authorise or when required by law to do so. You may exercise your rights of access, right to rectification, to object, to erasure, to restriction of processing, data portability and not to be subject to automated individual decision-making. To exercise these rights, as well as to obtain additional information about the processing of your personal data, you can consult the following link Terms and Conditions